Opium licensing

This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages) This article's lead section may be too short to adequately summarize the key points. Please consider expanding the lead to provide an accessible overview of all important aspects of the article. (December 2021) This article's lead section contains information that is not included elsewhere in the article. If the information is appropriate for the lead of the article, this information should also be included in the body of the article. (December 2021) (Learn how and when to remove this message) This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. Find sources: "Opium licensing" – news · newspapers · books · scholar · JSTOR (December 2021) (Learn how and when to remove this message) (Learn how and when to remove this message)

Opium licensing is a policy instrument used to counter illegal drug cultivation and production.^{[not verified in body]} It has been used in countries such as Turkey and India to curb illegal opium production.^{[not verified in body]} The main mechanism used under opium licensing is a shift from cultivation and/or production for the illegal market towards legal uses such as the production of essential medicines such as morphine and codeine.

A major contributor to this article appears to have a close connection with its subject. It may require cleanup to comply with Wikipedia's content policies, particularly neutral point of view. Please discuss further on the talk page. (March 2010) (Learn how and when to remove this message)

This section's factual accuracy may be compromised due to out-of-date information. The reason given is: This proposal is over ten years old and relates to a previous administration. What has happened since then?. Please help update this article to reflect recent events or newly available information. (December 2021)

Currently,^[timeframe?] an international think tank called The International Council on Security and Development (ICOS), formerly known as The Senlis Council, is investigating whether this policy option could be used to solve the massive drug problem in Afghanistan.^[1] The organization is calling for a new village-based poppy for medicines system that would be able to boost rural development, create stability and increase the grip the Karzai administration has on isolated poppy growing areas in the country. Equally, cheap Afghan-made could respond to the acute shortage of poppy-based medicines internationally. In June 2007, the Council released a technical blueprint for a poppy for medicine project in Afghanistan and called for a pilot project to create Afghan Morphine to be put in place at the next planting season (see The Senlis Council: "Poppy for Medicine" Poppy for Medicine)

The Bush administration objected to ICOS's recommendations. In February 2007, the U.S. Department of State, through the Bureau of International Narcotics and Law Enforcement Affairs, issued a response to the ICOS's proposal. They argued that the price difference between licit and illicit poppies would discourage farmers from participating, a problem that could be overcome only by massive subsidies. The United Nations International Narcotics Control Board finds little to no unmet demand for licit Afghan poppies in international markets. While Turkey, India, Pakistan, and Bolivia have adopted similar plans, decades of conflict have left most of Afghanistan country radically underdeveloped, both economically and institutionally. Large portions of the country remain largely under the control of Taliban insurgents, and these conditions pose serious difficulties for a successful licensing program.^[2]